Bod Australia Ltd ( (AU:BOD) ) has issued an announcement.
Bod Science Limited has announced a change in its registered office and principal place of business to a new address in Sydney, Australia. This move, approved by the Deed Administrator, reflects the company’s ongoing restructuring efforts under a Deed of Company Arrangement. The change is part of Bod’s strategic initiatives to strengthen its operational framework and potentially improve its market positioning.
More about Bod Australia Ltd
Bod Science Limited is a cannabis-focused drug development and product innovation company. It is dedicated to advancing research and development with a clinical trial pathway to commercialize scientifically proven products. The company collaborates with large corporations and leading research organizations to enhance the use of cannabis-related medicines for therapeutic purposes.
Technical Sentiment Signal: Sell
Current Market Cap: A$4.26M
Find detailed analytics on BOD stock on TipRanks’ Stock Analysis page.